FirstHealth Outpatient Cancer Center — Pinehurst, North Carolina

FirstHealth Outpatient Cancer Center is a clinical research site located in Pinehurst, North Carolina, United States 28374.

Crixeo Clinical Trials Trust Score: 21/100 (FAILING). This profile has not yet been claimed by the site owner.

FirstHealth Outpatient Cancer Center has participated in 18 clinical trials with 8 currently active.

Therapeutic areas: Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive, Platinum-resistant Ovarian Cancer, Non-Small Cell Lung Cancer.

Sponsors: Pfizer, Genmab, Gilead Sciences.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Pinehurst

Browse all research sites in North Carolina · View every site in Pinehurst

Sponsor Feasibility Report

Trust Score: 21/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for FirstHealth Outpatient Cancer Center?

FirstHealth Outpatient Cancer Center has a Crixeo Trust Score of 21/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has FirstHealth Outpatient Cancer Center conducted?

FirstHealth Outpatient Cancer Center has 18 clinical trials on record, with 8 currently active. Their work covers Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive, Platinum-resistant Ovarian Cancer, Non-Small Cell Lung Cancer.

Is FirstHealth Outpatient Cancer Center accredited by Crixeo Clinical Trials?

FirstHealth Outpatient Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about FirstHealth Outpatient Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.